DBV TECHNOLOGIES (EPA:DBV)

BRIEF

published on 11/13/2025 at 17:56, 21 days 15 hours ago

Artisan Partners exceeds 5% of the capital in DBV Technologies

Biopharmaceutical Shareholding Crossing Thresholds DBV Technologies Artisan Partners
BRIEF

published on 11/12/2025 at 05:55, 23 days 3 hours ago

DBV Technologies: Last patient visit in the SPEED trial

Clinical Trial Phase 3 DBV Technologies Peanut Allergy Viaskin® Peanut
PRESS RELEASE

published on 11/12/2025 at 05:50, 23 days 3 hours ago

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies completes last patient visit in Phase 3 VITESSE Clinical Trial of VIASKIN Peanut Patch for peanut allergic children aged 4-7 years; on track for Q4 data announcement

Clinical Trial DBV Technologies Peanut Allergy VITESSE Phase 3 Viaskin Peanut Patch
BRIEF

published on 11/04/2025 at 22:35, 1 month ago

DBV Technologies is participating in a healthcare innovation conference

DBV Technologies Viaskin Food Allergies Health Conference EPIT
PRESS RELEASE

published on 11/04/2025 at 22:30, 1 month ago

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
DBV Technologies to participate in Guggenheim 2nd Annual Healthcare Innovation Conference with CEO Daniel Tassé at the helm, discussing treatment options for food allergies

Healthcare Innovation DBV Technologies Food Allergies VIASKIN Patch Guggenheim Conference
BRIEF

published on 10/30/2025 at 21:35, 1 month 5 days ago

DBV Technologies Appoints Philina Lee, Ph.D. to Board of Directors

Board Of Directors Biopharmaceutical DBV Technologies Viaskin Peanut Philina Lee
PRESS RELEASE

published on 10/30/2025 at 21:30, 1 month 5 days ago

DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
DBV Technologies appoints Dr. Philina Lee, Ph.D. as independent director to Board of Directors, bringing extensive biopharmaceutical experience. Company focused on VIASKIN® Peanut for food allergies

Board Of Directors DBV Technologies Food Allergies Viaskin Peanut Dr. Philina Lee
BRIEF

published on 10/28/2025 at 21:30, 1 month 7 days ago

DBV Technologies Announces Q3 2025 Financial Results

Financial Results Treasury Funding Net Loss Viaskin Peanut
PRESS RELEASE

published on 10/28/2025 at 21:25, 1 month 7 days ago

DBV Technologies Reports Third Quarter 2025 Financial Results
DBV Technologies reports Q3 2025 financial results with a cash balance of $69.8M, projecting cash runway into Q3 2026. Details on operating income, expenses, net loss, cash flow, and funding activities

Financial Results Cash Balance DBV Technologies Funding Activities Q3 2025
BRIEF

published on 10/14/2025 at 15:49, 1 month 21 days ago

Change of Participation at DBV Technologies

Capital Increase Threshold Crossing DBV Technologies Invus Public Equities Contracts For Differences

Published on 12/05/2025 at 02:35, 7 hours 1 minute ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 6 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 36 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 31 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 36 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

Published on 12/05/2025 at 09:05, 31 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 35 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 36 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 36 minutes ago

Official List Notice
Published on 12/05/2025 at 09:00, 36 minutes ago

Petershill Partners plc - Removal

View all EQS

Published on 12/05/2025 at 08:45, 51 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 36 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 51 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 52 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE

News